Tekst voor de linkerkolom.

Tekst voor de rechterkolom.

Titel van het highlightblok

Voeg hier de tekst toe die extra aandacht verdient.
ImmuneHealthSeed: Determining immune profiles of patients with Immune Mediated Inflammatory Diseases for immune-targeting medicines.
ImmuneHealthSeed: Determining immune profiles of patients with Immune Mediated Inflammatory Diseases for immune-targeting medicines.

ImmuneHealthSeed: Determining immune profiles of patients with Immune Mediated Inflammatory Diseases for immune-targeting medicines.

Disease-overarching immune profiles to tailor treatment for the million patients with autoimmune diseases

Periode
-
Looptijd
48 months
Deel van call / Programma
/
Projectpartners
LUMC
Friesland Campina
Sanquin
RUMC
Erasmus MC
Social English
Images (6)
Download (11)
Maxresdefault (1)
Epimune Diagnostics
Minacned Leden Needle
Angany
Images (7)

From academia and private partners, a team of experts in disease-overarching immunology, and preclinical and clinical disease-specific experts aims to decipher disease-overarching immune profiles and regulatory networks in patients with immune-mediated inflammatory diseases. ImmuneHealthSeed is the first foundation to build towards the larger initiative ImmuneHealthXL. We envision fruitful long-term collaborations to accelerate the development of novel treatments and diagnostics to improve the quality of life for all who are affected by immune-mediated diseases.

In many diseases, the immune system plays an important role. Worldwide, millions of lives can be saved by immune-modulating curative cancer treatments (over 8 million worldwide annually). Furthermore, hundreds of millions of chronic inflammatory diseases (5 to 7% of the Western society) and patients suffering from allergies (10-30% of the world population) would benefit from a curative immune-modulating treatment approach rather than life-long daily treatments.

Yet, a disease-overarching approach focusing on a fundamental understanding of the different disease pathways is lacking. Much is to be gained in a fuller understanding of immune homeostasis: an immune system fit enough to fight off viruses but not so aggressive that it attacks healthy tissue.

We will monitor patient-reported immunological disease activity via serum/plasma immune proteomics and identify common underlying immune mechanisms driving (re)activation of disease-associated dendritic cell (DC)-T-B cell networks. In parallel, we will design novel nanotherapeutic immunotherapies to counter disease reactivation mechanisms. We will generate various formulations of tolerance-inducing- or immune-silencing nanoparticles and evaluate which formulation is best suited.

This project will lay the foundations for curative treatments for immune-mediated diseases. The potential societal and economic impact of this project is therefore huge.

ImmuneHealthSeed

Projects

Other projects

In each PPP project, research institutions, businesses and healthcare organisations work together on a specific health challenge. Browse the full project overview.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.